BlackRock’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,115
Closed -$91.6K 5385
2023
Q3
$91.6K Buy
+8,115
New +$97.2K ﹤0.01% 4868
2022
Q4
Sell
-122,025
Closed -$1.59M 5770
2022
Q3
$1.59M Sell
122,025
-1,537
-1% -$18.9K ﹤0.01% 4298
2022
Q2
$1.69M Buy
123,562
+4,078
+3% +$54.1K ﹤0.01% 4317
2022
Q1
$1.63M Buy
119,484
+33,253
+39% +$439K ﹤0.01% 4470
2021
Q4
$1.22M Buy
86,231
+10,111
+13% +$140K ﹤0.01% 4602
2021
Q3
$1.03M Sell
76,120
-2,425
-3% -$32.7K ﹤0.01% 4542
2021
Q2
$1.1M Buy
78,545
+74,978
+2,102% +$1.06M ﹤0.01% 4486
2021
Q1
$36K Sell
3,567
-3,631
-50% -$30.5K ﹤0.01% 4956
2020
Q4
$45K Buy
+7,198
New +$40.9K ﹤0.01% 4686

Other funds holding BIOX

BlackRock's BIOX Position: Q4 2023 in Review

BlackRock sold out of Bioceres Crop Solutions (BIOX) in Q4 2023, closing a stake of 8,115 shares — an estimated $91.6K sold.

BlackRock first reported a position in BIOX in Q4 2020 and held it in 9 quarters. The position peaked at $1.69M in Q2 2022. 51 funds tracked by Wall St. Rank hold BIOX as of Q4 2023.

  • BlackRock reported no remaining Bioceres Crop Solutions position as of Q4 2023 after selling out during the quarter.
  • BlackRock sold 8,115 Bioceres Crop Solutions shares in Q4 2023, an estimated $91.6K.
  • BlackRock first reported a position in Bioceres Crop Solutions in Q4 2020 and held it in 9 quarters.
  • BlackRock's Bioceres Crop Solutions position peaked at $1.69M in Q2 2022.
  • 51 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2023.

Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.